Stephens & Co. Reiterates Overweight on Encompass Health, Maintains $94 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Scott Fidel has reiterated an Overweight rating on Encompass Health (NYSE:EHC) and maintained a price target of $94.
June 05, 2024 | 2:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stephens & Co. analyst Scott Fidel has reiterated an Overweight rating on Encompass Health (NYSE:EHC) and maintained a price target of $94.
The reiteration of an Overweight rating and the maintenance of a $94 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100